Tag Archives: Cisplatin

A New Method to Treat Chemotherapy-Induced Neuropathic Pain

Posted on March 12, 2012 by wngai

If you are cancer patients and have to receive chemotherapy agents such as taxanes (paclitaxol- Taxol and docetaxel-Taxotere), vinca alkaloids (vinorelbine-Navelbine) and platinum compounds (cisplatin, carboplatin – Paraplatin and oxaliplatin – Eloxatin), it is likely that you might experience chemotherapy … Continue reading →

Posted in Anal Cancer, Bladder Cancer, Breast cancer, Cancer, Colorectal cancer, Endometrial Cancer, Esophageal Cancer, Gallbladder cancer, Gastric Cancer, Glioblastma, Head and Neck Cancer, Liver Cancer, Lung Cancer, Melanoma, Nasopharyngeal Cancer, Non Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate cancer, Renal Cancer, Small Cell Lung Cancer | Tagged , , , , , , , , , , , , , , , , | Comments Off on A New Method to Treat Chemotherapy-Induced Neuropathic Pain

Which is Best Chemotherapy Option for Advanced Bladder Cancer?

Posted on May 15, 2011 by wngai

Transitional cell or urothelial carcinoma is the most common type of bladder cancer, accounting for more than 90% all bladder cancers.  This type of cancer is sensitive to treatment with chemotherapeutic agents.   This type of cancer is usually treated with … Continue reading →

Posted in Bladder Cancer, Cancer | Tagged , , , , , , , , , , | Comments Off on Which is Best Chemotherapy Option for Advanced Bladder Cancer?

Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer

Posted on October 16, 2010 by wngai

Patients with triple negative breast cancer usually have poor prognosis, but a new drug might soon be available to improve the survival in these patients.   Mid-stage study results presented at the European Society for Medical Oncology congress indicated that cetuximab(Erbitux) … Continue reading →

Posted in Breast cancer, Cancer | Tagged , , , , , | Comments Off on Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer

A New Treatment Option for patients with Gastric Cancer

Posted on September 12, 2010 by wngai

 Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related deaths worldwide.  Previous study has found that patients with operable disease have a 5-year survival rate of 36%.  In patients with advanced or … Continue reading →

Posted in Cancer, Gastric Cancer | Tagged , , , , , , , , , | Comments Off on A New Treatment Option for patients with Gastric Cancer

New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine

Posted on April 11, 2010 by wngai

Good news for patients with advanced biliary tract cancer.  Combination of cisplatin and gemcitabine (Gemzar) have been shown to be an effective treatment option for patients with locally advanced or metastatic biliary tract cancer.  In developed nations, biliary tract cancer … Continue reading →

Posted in Cancer, Gallbladder cancer | Tagged , , , , , , | Comments Off on New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine

Alternative 1st Treatment for Small-Cell Lung Cancer Patients with Extensive Disease

Posted on March 28, 2010 by wngai

Lung cancer is the most common diagnosed cancer worldwide and small-cell lung cancer (SCLC) accounts for only 10%-15% of lung cancer cases.  Etoposide in combination with cisplatin (EP) or carboplatin is currently considered the standard of care in most countries, but … Continue reading →

Posted in Cancer, Lung Cancer | Tagged , , , , , , | Comments Off on Alternative 1st Treatment for Small-Cell Lung Cancer Patients with Extensive Disease